Pleio, Inc. Bolsters Patient Adherence Efforts with Appointment of Mark Gregory as Chief Pharmacy Officer
Retrieved on:
Thursday, August 25, 2022
NEW YORK, Aug. 25, 2022 /PRNewswire/ -- Pleio, Inc., (https://www.pleio.com/), a leader in healthcare technology and medication support programs, has announced the appointment of Mark Gregory to the newly created position of Chief Pharmacy Office (CPO). Mark Gregory brings more than three decades of experience in pharmacy and healthcare to the role. His appointment reinforces Pleio's commitment to drive change through their unique patient engagement platform, which is designed to solve the multiple impacts that medication non-adherence has on human health.
Key Points:
- Mark Gregory brings more than three decades of experience in pharmacy and healthcare to the role.
- "Adding Mark Gregory as Chief Pharmacy Officer represents an exciting evolution of our company and of the industry.
- Mark represents the best of the pharmacy and healthcare industries, having assembled winning teams as both a pharmacist and corporate executive."
- "It is very rewarding to be joining a great team of professionals at Pleio as Chief Pharmacy Officer," said Mark Gregory.